Impax Laboratories, Inc. (IPXL) stock slips, “Sector Perform” rating reaffirmed by RBC Capital Markets Analysts

Impax Laboratories, Inc. (NASDAQ: IPXL) shares fell on Tuesday January 17 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, in early trade, the Dow Jones Industrial Average was 47 points lower, or 0.24% to 19838, the S&P 500 fell 7 points, or 0.29% to 2267, while the Nasdaq was down 19 points, or 0.35% to 5554.

Easy Guide to Investing in the Stock Market

Analysts at RBC Capital Markets reiterated a Sector Perform rating on shares of Impax Laboratories, Inc. (NASDAQ: IPXL) in a reserach note to investors, making it one of the more closely watched stocks on Wall Street. RBC Capital Markets currently has a rating of Sector Perform on the shares. The one-year price target of $18.53 is above the opening price of $13.10, that has caused a fair amount of other analysts to report on the stock in recent days. Looking back over the last 52 weeks, Impax Laboratories, Inc. stock has a high of $40.74. Typically, after analysts give a “reiterated rating” report on a stock, they will later issue other updates, often followed by a price target change.

Shares of Impax Laboratories, Inc. (NASDAQ: IPXL) opened at $13.10 yesterday and traded in a range between, $12.60 and $13.15, and last traded at $12.75, which represents a dip of $0.10 from the previous closing price.

Impax Laboratories, Inc. (NASDAQ: IPXL) currently has a market cap of 909.46M.

Impax Laboratories, Inc. (NASDAQ: IPXL) Average Daily Trading Volume

The stock’s average daily volume is 1,331,350 shares out of a total float 60,346,000 and some 346,185 shares crossed the trading desk yesterday, 63 percent below the average. lower than normal. Look for trading volume to pick up in the coming days as investors often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these have substantial teams of analysts that investigate thousands of stocks, so it is good validation to see them taking a postion in a stock you are researching.

Impax Laboratories, Inc. (NASDAQ: IPXL) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for Impax Laboratories, Inc. (NASDAQ: IPXL) have ranged from $11.88 – 40.74, and the stock now has a 50-day MA of $13.66 and 200-day MA of $22.19. Today’s last price is 68.70%% below the 52 week high of $40.74.

Earnings growth is an important factor to look at when buying stocks and investors seek companies that have increased their earnings at least 25% or more over a 3 year period.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply